Medscape Medical News talked with researcher Stacie Dusetzina about the prospects for a single-payer program to help with the ...
Morning Overview on MSN
New research links cancer therapy and synthetic biology in a major leap
Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...
Pea-size clusters of human cells called brain organoids inspire both hope and fear. Experts are debating how scientists can ...
REITs are positioned for multi-year outperformance, with accelerating AFFO growth, healthy balance sheets, and discounted ...
According to Withings, the new body analysis scale can capture over 60 clinically relevant biomarkers in just 90 seconds.
Steel Horse Rides on MSN
The 2026 Tesla Model 3 still has meaningful range at 'empty'
The 2026 Tesla Model 3 has quietly reframed what “empty” means in an electric car, turning the dreaded 0 percent warning into ...
While observing the rapid evolution of medical tourism, the Liv model warrants a closer look. It offers a useful reference ...
The Porsche 964, in production from 1989 through 1994, presents the 911 model’s ideal chassis, engine, and aesthetic.
Finnish technology company Donut Lab has unveiled a solid-state battery that is now available for OEM use and will be ...
“Expression tells us what cells do, but regulatory DNA tells us where they come from, how they develop, and which germ layer ...
Artificial intelligence is intended to help reduce human labor, but classrooms are for humans to learn through labor. Where ...
Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results